Garuda Therapeutics Stock

garudatx.comHealthcareFounded: 2021

Garuda Therapeutics offers platform technology that aids in the development of off-the-shelf hematopoietic stem cell (HSC) therapies that treat a range of severe and life-threatening diseases. The goal of the company is to make it easier for patients to access stem-cell therapies by providing consistent, durable, and HLA-compatible treatments for a broad range of diseases. Garuda Therapeutics was founded in the Boston, Massachusetts area in 2021.

Register for Details

For more details on financing and valuation for Garuda Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Garuda Therapeutics.

Register Today

Other companies like Garuda Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 

News

Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced a $62 million Series B financing led by Northpond Ventures, OrbiMed Advisors, Cormorant Asset Management, and Aisling Capital.